产品详情
Targets
Target | Value |
---|---|
VEGFR1/FLT1 | IC50: 0.1nM |
VEGFR2/Flk1 | IC50: 0.18nM |
VEGFR2/KDR | IC50: 0.2nM |
VEGFR3 | IC50: 0.1nM-0.3nM |
PDGFRβ | IC50: 1.6nM |
Kit | IC50: 1.7nM |
PDGFRα | IC50: 5.0nM |
CSF-1R | IC50: 73nM |
FLT3 | IC50: >1μM |
In vitro | DMSO | Warmed: 30 mg/mL (77.62 mM) | |
Water | Insoluble | ||
Ethanol | Insoluble | ||
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 25.87 mL | 129.37 mL | 258.73 mL |
0.5 mM | 5.17 mL | 25.87 mL | 51.75 mL |
1 mM | 2.59 mL | 12.94 mL | 25.87 mL |
5 mM | 0.52 mL | 2.59 mL | 5.17 mL |
*The above data is based on the productmolecular weight 386.5 . Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
目录号 | A10103 |
---|---|
作用机制 | Inhibitor (抑制剂) |
M. Wt | 386.5 |
Formula | C22H18N4OS |
Purity | >99% |
Storage | Store lyophilized at -20ºC, keep desiccated. |
CAS No. | 319460-85-0 |
Synonyms | AG 013736 |
SMILES | CNC(=O)C1=CC=CC=C1SC2=CC3=C(C=C2)C(=NN3)/C=C/C4=CC=CC=N4 |
产品标签
Product Questions
Product Questions
Brivanib alaninate (BMS-582664)
Brivanib alaninate (BMS-582664)是VEGFR和FGFR信号转导的双重酪氨酸激酶抑制剂。
BMS-690514
BMS-690514是一种有效的选择性表皮生长因子受体(EGFR),HER2和HER4抑制剂,以及VEGF受体激酶。
Imatinib (Gleevec)
Imatinib (Gleevec)是一种多靶点酪氨酸激酶抑制剂,抑制v-Abl、c-Kit和PDGFR的IC50分别为0.6,0.1和0.1 μM。
Raf265 derivative
Raf265 derivative是Raf265的衍生物,Raf265是一种口服,高度选择性的RAF和VEGFR激酶抑制剂,IC50为5至10μM。
SU 5416 (Semaxinib)
SU 5416 (Semaxinib)是血管内皮生长因子受体(VEGFR)的抑制剂,它还抑制其他酪氨酸激酶KIT,MET,FLT3和RET。
TSU-68 (Orantinib, SU6668)
TSU-68 (Orantinib,SU6668)在无细胞试验中具有8 nM的Ki对PDGFR自磷酸化的最大效力,但也强烈抑制Flk-1和FGFR1反磷酸…